-
TPVG Q2 2026 net investment income $0.21/sh; declares $0.23 regular + $0.12 supplemental distributions
Net increase in net assets resulting from operations of $10.7M ($0.26/sh) vs $13.2M ($0.33/sh) in Q2 2025.
-
TPVG Q1 NII $0.23/share, down from $0.27 YoY; declares $0.23 dividend; authorizes $12.5M buyback
Net investment income $9.1M ($0.23/share) vs $10.7M ($0.27) in Q1 2025; total investment income $22.8M vs $22.5M.
-
TPVG annual meeting results: all director nominees elected, Deloitte ratified as auditor
James P. Labe, Cynthia M. Fornelli, Katherine J. Park elected as Class III directors.
-
TPVG reports FY2025 NII of $1.05/share; NAV rises to $8.73; declares $0.23 Q1 distribution
NII of $42.3M ($1.05/sh) for FY2025 vs $54.5M ($1.40/sh) in FY2024; Q4 NII $9.9M ($0.25/sh).
-
TriplePoint Venture BDC issues $75M 7.5% senior notes due 2028, repays $200M 4.5% notes
Issued $75M of 7.50% Series 2026 Senior Notes due Feb 27, 2028 via private placement.
-
TPVG amends credit facility, extends revolving period to 2027, maturity to 2029 with improved terms
Extended revolving period to Nov 30, 2027, and maturity to May 30, 2029.
-
TPVG Q3: NII $0.26/sh; debt commitments at 3-yr high; dividend $0.25/sh; adviser extends fee waiver
NII $10.3M ($0.26/sh); net increase in net assets $15.2M ($0.38/sh) for Q3 2025.
-
TPVG declares Q4 2025 regular $0.23/sh and supplemental $0.02/sh distributions; Q3 earnings call Nov 5
Regular quarterly distribution of $0.23 per share for Q4 2025, payable Dec 30, 2025 to holders of record Dec 16, 2025.
-
TPVG Q2 2025 NII $0.28/sh; NAV $8.65; declares $0.23 dividend; Sponsor to buy up to $14M stock
Closed $160.1M debt commitments, highest in 3 years; funded $78.5M, up 188% QoQ.
-
TPVG Q1 net increase from ops $0.32/share; NII $0.27/share; declares $0.30 dividend
Net investment income of $10.7M ($0.27 per share) vs $15.5M ($0.41) in Q1 2024; total investment income $22.5M vs $29.3M.
-
TriplePoint Venture Growth BDC holds annual meeting, elects directors and ratifies auditor
Elected Class II directors: Gilbert E. Ahye (7,058,868 for), Steven P. Bird (7,100,334 for), Kimberley H. Vogel (7,057,036 for).
-
TriplePoint Venture Growth Q4 NII $0.32/share; FY 2024 NII $1.40/share; declares Q1 dividend $0.30
Q4 2024 NII $12.6M ($0.32/share) vs $17.3M ($0.47/share) in Q4 2023; total investment income $25.8M.
-
TPVG issues $50M senior unsecured notes at 8.11% due 2028 to refinance March 2025 maturity
$50M aggregate principal of 8.11% fixed-rate notes due February 12, 2028, issued in private placement.
-
TriplePoint Venture Growth BDC appoints Mike L. Wilhelms as CFO effective Jan 6, 2025
Mike L. Wilhelms appointed CFO effective Jan 6, 2025, replacing interim CFO Matthew Galiani.
-
TPVG Q3 NII $0.35/sh, NAV $9.10 (+$0.27); declares Q4 $0.30 distribution
Net investment income $13.8M ($0.35/sh) vs $19.1M ($0.54/sh) in Q3 2023.
-
Court dismisses securities class action against TriplePoint Venture Growth BDC without leave to amend
On August 7, 2024, the U.S. District Court for N.D. Cal. granted defendants' motion to dismiss the putative class action (Case 3:23-cv-02980).
-
TriplePoint Venture Growth extends credit facility, reduces commitments to $300M, maturity to May 2027
Revolving period extended to Nov 30, 2025; maturity extended to May 30, 2027.
-
TPVG Q2 2024 NII $0.33/shr vs $0.53 last year; NAV $8.83; dividend $0.30
Net investment income $12.6M ($0.33/shr) vs $18.8M ($0.53) a year ago; total investment income $27.1M.
-
TriplePoint Venture Growth appoints Matthew Galiani as interim CFO
Matthew A. Galiani appointed interim CFO effective Aug 9, 2024.
-
TriplePoint VC BDC CFO Christopher Mathieu to retire Aug 9, 2024; search underway
Christopher Mathieu retires as CFO effective Aug 9, 2024; will serve as advisor through Dec 31, 2024.
-
TriplePoint Venture Growth BDC enters $75M ATM equity offering with UBS
New sales agreement with UBS Securities LLC for up to $75M of common stock (TPVG).
-
TPVG Q1 NII $0.41/share, total investment income $29.3M; NAV $9.02
Net investment income $15.5M ($0.41/share) vs $18.6M ($0.53/share) in Q1 2023.
-
TPVG stockholders elect Srivastava and Cassani as Class I directors; ratify Deloitte
Annual meeting held April 25, 2024; 25,318,446 shares voted out of 37,620,109 eligible.
-
TPVG reports FY2023 NII $2.07/share, NAV down to $9.21, Q4 realized losses $52M
Net investment income FY2023: $73.8M or $2.07 per share; Q4 NII $17.3M or $0.47 per share.
-
TriplePoint Venture Growth Q3 NII $0.54/share, declares $0.40 distribution
NII $19.1M ($0.54/share) up from $16.9M ($0.51) YoY; total investment income $35.7M.
-
TPVG borrower ForgeRock acquired; $30M loan prepaid, $3.6M fees, $2.3M income acceleration
ForgeRock acquired by Thoma Bravo in $2.3B all-cash deal; TPVG's $30.0M loan fully prepaid.
-
TriplePoint Venture Growth Q2 NII $0.53/sh; NAV down to $10.70; declares $0.40 dividend
Q2 NII $18.8M ($0.53/sh) vs $12.7M ($0.41) in Q2 2022; total investment income $35.2M.
-
TriplePoint Venture Growth Q1 NII $0.53/share; three portfolio companies file for bankruptcy
Net investment income $18.6M ($0.53/share); total investment income $33.6M; NAV $414.0M ($11.69/share).
-
TriplePoint Venture Growth BDC reelects three Class III directors, ratifies auditor
24,051,889 shares voted out of 35,348,049 eligible at April 27, 2023 annual meeting.
-
TriplePoint Venture Growth BDC reports no direct exposure to SVB or Signature Bank closures
Company has no deposit accounts, payment processing, or credit facilities with SVB or Signature Bank.
-
TPVG reports record Q4 NII of $0.58/share; raises dividend 8% to $0.40
Record Q4 total investment income $34.9M; net investment income $20.5M ($0.58/share).
-
TriplePoint borrower Medly Health files Ch 11; TPVG expects full write-down of investments
Medly Health Inc. filed for Chapter 11 on Dec 9, 2022 due to irregularities and liquidity issues.
-
TriplePoint Venture Growth BDC declares $0.10 special distribution for Dec 30, 2022
Special distribution of $0.10 per share payable Dec 30, 2022 to record Dec 22, 2022.
-
TriplePoint Venture Growth posts record Q3 portfolio fair value $962M, NII $0.51/sh, raises dividend to $0.37
Record portfolio fair value of $962M and net investment income of $16.9M ($0.51/sh) for Q3 2022.
-
TriplePoint Venture Growth BDC Corp. enters into $50M at-the-market offering with UBS Securities
Sales Agreement with UBS Securities for up to $50M of common stock, no minimum sales obligation.
-
TriplePoint Venture Growth Amends 8-K to Correct Share Count in August 2022 Offering
Amendment corrects number of shares issued to 3,750,000 (plus 562,500 option) in Aug 4, 2022 offering.
-
TriplePoint Venture Growth BDC raises ~$49.8M in public offering of 3.5M shares
Entered underwriting agreement Aug 4, 2022 for 3,500,000 common shares (plus 562,500 option).
-
TPVG Q2 NII $0.41, record portfolio $877M; NAV slips to $13.01, Q3 dividend $0.36
Net investment income $12.7M ($0.41/share); 14.5% weighted avg portfolio yield on debt.
-
TriplePoint Venture Growth BDC extends credit facility revolving period to May 2024, maturity to Nov 2025
Amended receivables financing agreement: revolving period extended from Nov 30, 2022 to May 31, 2024.
-
TriplePoint Venture Q1 NII $0.44/share, declares $0.36 dividend
Net investment income of $13.5M ($0.44/share), up from $0.42/share prior quarter; 12.6% ROE.
-
TPVG stockholders elect three Class II directors and ratify Deloitte as auditor
20,245,547 of 31,010,853 eligible shares voted at April 28, 2022 annual meeting.
-
Q4 NII $0.42/sh, record portfolio $865M; declares $0.36 Q1 dividend
Net investment income $12.9M ($0.42/sh) in Q4, up from $9.9M ($0.32/sh) prior quarter; FY2021 NII $41.1M ($1.33/sh).
-
TPVG closes $125M private placement of 5.00% Senior Notes due 2027
$125M aggregate principal, 5.00% fixed rate, matures Feb 28, 2027.
-
TriplePoint Venture Growth expands board to eight, adds two independent directors
Board increased from six to eight members; Park (Class III) and Vogel (Class II) appointed effective Dec 17, 2021.
-
TriplePoint Venture Growth posts record portfolio fair value $767M; NAV per share up $0.89 to $13.92
Record portfolio fair value of $767M; NAV per share increased $0.89 to $13.92 (7% QoQ).
-
TPVG Q2 2021 NII $0.30/share, NAV $13.03; declares $0.36 Q3 dividend
Net investment income of $9.4M ($0.30/share) vs $11.5M ($0.38) in Q2 2020.